Interviews

NEYROS CEO Discusses Joint Research with Cuba on New Parkinson’s Medication

• Bookmarks: 19


NEYROS, a company of the Russian Federation, is a research institution in the SKOLKOVO Innovation Center of Moscow. The Company conducts research and development for new pharmaceutical drug candidates to treat neurodegenerative disorders such as age-related Dementia, Parkinson’s disease, Alzheimer’s disease, cerebrovascular ischemia and melanoma. NEYROS is a startup company which shares an agreement for collaboration with Cuba’s CIDEM, an institution under the umbrella of BioCubaFarma, to study neurological diseases. Dr. Dmitry Chelovskiy is the CEO of NEYROS. Our editor spoke with Dr. Chelovskiy in March of this year.…

TO READ THE FULL STORY:

 SUBSCRIBE

 SIGN IN

Unbiased reporting on economic news and business developments in Cuba by industry sector

 

comments icon0 comments
bookmark icon

Write a comment...

error: This content is copyright protected.